Previous work in mice revealed that impaired processing of APP leads to excessive production of sAPPα, at a critical developmental period (Post-natal day 21, P21), contributing to molecular, cellular, and behavioral FXS phenotypes [18,20,40]. This evidence concerns the gene APP and fragile X syndrome.